Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_assertion type Assertion NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_head.
- NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_assertion description "[c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_provenance.
- NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_assertion evidence source_evidence_literature NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_provenance.
- NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_assertion SIO_000772 1352125 NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_provenance.
- NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_assertion wasDerivedFrom befree-2016 NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_provenance.
- NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_assertion wasGeneratedBy ECO_0000203 NP411118.RA9O9L0qIoG_hSChfmtPdWlqhDxp5scCsZ6TGYIPsRHk0130_provenance.